Lifecore Biomedical, Inc. LFCR
4.20
(0.09)
(2.10%)
as of 25 Sep
- Market cap
- $162.4M
- P/E
- 0.0×
Follow LFCR
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 201.15% | 293.76% | 0.00% | (1,055.37%) |
+8 more TTM periods Free account |
|
| (19.32%) | (35.31%) | 0.00% | (22.04%) | ||
ROIC |
(2.80%) | (2.32%) | 0.00% | (3.95%) | |
Return on Tangible Assets |
(24.16%) | (21.79%) | 0.00% | (14.20%) | |
Average Days of Receivables |
92.96 | 58.22 | 0.00 | 72.37 | |
Free Cash Flow per Share |
(0.13) | 0.36 | — | 0.35 | |
Free Cash Flow |
(5.06) | 13.50 | — | 13.17 | |
Capital Expenditures |
(4.55) | (0.27) | — | (1.25) | |
Piotroski F-Score |
2.00 | 4.00 | — | 4.00 | |
| Other line items | |||||
Cash ROIC |
(0.23%) | 7.28% | 0.00% | 6.67% | |
Accounts Receivable Turnover |
4.33 | 5.06 | 0.00 | 4.53 | |
Accounts Payable Turnover |
9.91 | 11.53 | 0.00 | 6.90 | |
Inventory Turnover |
2.95 | 2.91 | 0.00 | 2.37 | |
Average Days of Payables |
31.44 | 29.15 | 0.00 | 42.64 | |
Days of Inventory on Hand |
106.32 | 117.01 | 0.00 | 142.50 | |
Tax Rate |
0.02 | 0.02 | — | 0.03 | |
Research and Development Expense of Revenue |
5.59% | 5.95% | — | 6.51% | |
Selling, General and Administrative Expense of Revenue |
28.16% | 28.47% | — | 34.42% | |
Share Based Compensation of Revenue |
3.51% | (1.53%) | — | (1.40%) | |
Interest Coverage |
0.00 | 0.00 | — | 0.00 | |
Operating CF/Net income |
0.01 | (0.35) | — | (0.56) | |
Depreciation/Fixed assets |
0.04 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
(0.95) | (1.72) | — | 5.29 | |
Revenue per Share |
3.18 | 3.25 | — | 3.34 | |
Operating CF per Share |
(0.01) | 0.37 | — | 0.39 | |
Capex per Share |
(0.12) | (0.01) | — | (0.03) | |
Capex to Sales |
0.04 | 0.00 | — | 0.01 | |
Net Profit Margin |
(37.54%) | (32.67%) | — | (20.77%) |
Columns are period end dates